Regulating the Future: A Deep Dive into Healthcare AI Governance
The rapid adoption of artificial intelligence (AI) in healthcare has also accelerated both legislative and guidelines measures, each aiming to shape the future of AI applications in clinical environments.
Understanding the impact and effective ways to work with and select AI vendors in light of these measures is critical for ensuring successful AI initiatives across the health system.
With the 1,200+ pages (and counting) of regulatory material and guidelines to digest, what are some of the biggest takeaways today and what does this mean for the future of AI?
This session:
- Discusses why the rapid adoption and implementation of healthcare AI necessitates governance now
- Explores its impact on hospital leaders, physicians and patients
- Delves into recent guidelines, what they mean and what to expect from them
- Shares what AI governance looks like in the Healthcare system
Speakers:
- Karen Mandelbaum, Senior Counsel at Epstein Becker Green
- Sam Johnson, Principal at Deloitte Consulting LLP
- Bill Fera, MD, Principal at Deloitte Consulting LLP
- Shilpa Patel, Managing Director, Innovation & Product Strategy at the American College of Cardiology (ACC)
- Demetri Giannikopoulos, VP of Innovation, Aidoc
